Last Close
Feb 26  •  03:57PM ET
31.88
Dollar change
-1.72
Percentage change
-5.12
%
IndexRUT P/E25.07 EPS (ttm)1.27 Insider Own1.60% Shs Outstand156.86M Perf Week-10.60%
Market Cap4.99B Forward P/E14.92 EPS next Y2.14 Insider Trans1.66% Shs Float156.19M Perf Month-9.77%
Enterprise Value6.03B PEG1.25 EPS next Q0.40 Inst Own104.27% Short Float5.59% Perf Quarter6.55%
Income207.59M P/S0.88 EPS this Y8.72% Inst Trans-0.53% Short Ratio4.86 Perf Half Y14.18%
Sales5.65B P/B3.77 EPS next Y14.24% ROA5.86% Short Interest8.73M Perf YTD0.06%
Book/sh8.46 P/C21.44 EPS next 5Y11.90% ROE15.20% 52W High36.80 -13.37% Perf Year-3.83%
Cash/sh1.49 P/FCF22.97 EPS past 3/5Y15.40% - ROIC8.08% 52W Low24.24 31.55% Perf 3Y3.14%
Dividend Est.- EV/EBITDA14.75 Sales past 3/5Y12.72% 13.25% Gross Margin18.06% Volatility4.14% 3.29% Perf 5Y66.13%
Dividend TTM- EV/Sales1.07 EPS Y/Y TTM3.75% Oper. Margin5.98% ATR (14)1.21 Perf 10Y279.52%
Dividend Ex-Date- Quick Ratio0.96 Sales Y/Y TTM13.03% Profit Margin3.67% RSI (14)35.14 Recom1.18
Dividend Gr. 3/5Y- - Current Ratio1.53 EPS Q/Q3.45% SMA20-7.18% Beta0.84 Target Price40.10
Payout0.00% Debt/Eq0.96 Sales Q/Q8.84% SMA50-6.00% Rel Volume1.53 Prev Close33.60
Employees6528 LT Debt/Eq0.94 EarningsFeb 24 BMO SMA2004.08% Avg Volume1.80M Price31.88
IPOAug 15, 1996 Option/ShortYes / Yes EPS/Sales Surpr.-1.79% 0.25% Trades Volume2,724,861 Change-5.12%
Date Action Analyst Rating Change Price Target Change
Dec-11-25Initiated Stephens Overweight $40
Oct-02-25Initiated TD Cowen Hold $30
Apr-30-25Upgrade UBS Neutral → Buy $40
Jan-23-25Upgrade Jefferies Hold → Buy $26 → $35
Jan-13-25Upgrade BofA Securities Neutral → Buy $26 → $33
Dec-05-24Initiated UBS Neutral $26
Nov-04-24Downgrade Goldman Buy → Neutral $27
Oct-31-24Downgrade Jefferies Buy → Hold $38 → $26
Oct-30-24Downgrade BofA Securities Buy → Neutral $43 → $29
Jul-16-24Initiated JMP Securities Mkt Outperform $36
Feb-25-26 08:06PM
Feb-24-26 04:02PM
12:49PM
11:10AM
09:59AM
08:50AM Loading…
08:50AM
07:29AM
07:12AM
07:00AM
Feb-23-26 06:15PM
Feb-22-26 10:10PM
Feb-10-26 07:55AM
Feb-06-26 09:21AM
Feb-02-26 12:27PM
Jan-30-26 11:56AM
04:05PM Loading…
Jan-29-26 04:05PM
Jan-27-26 12:10PM
Jan-21-26 04:05PM
Jan-14-26 01:11PM
07:11AM
Jan-13-26 07:29PM
06:32PM
04:35PM
03:40PM
11:17AM
Jan-12-26 04:35PM
Dec-22-25 09:14AM
Dec-19-25 09:13AM
Dec-12-25 07:00AM
Dec-09-25 11:21AM
07:00AM Loading…
Nov-28-25 07:00AM
Nov-26-25 03:00AM
Nov-25-25 10:40PM
Nov-21-25 06:45PM
Nov-06-25 12:39AM
Nov-03-25 04:05PM
Oct-31-25 09:55AM
Oct-30-25 04:32PM
03:35PM
08:52AM
08:15AM
07:14AM
07:00AM
Oct-29-25 11:59AM
Oct-28-25 11:03PM
Oct-23-25 10:00AM
Oct-22-25 09:21AM
Oct-21-25 12:10PM
Oct-18-25 01:50AM
Oct-17-25 09:36AM
Oct-16-25 09:40AM
Oct-14-25 11:40AM
Sep-30-25 09:40AM
Sep-25-25 04:05PM
Sep-23-25 03:26PM
Sep-17-25 01:30AM
Aug-25-25 04:05PM
Aug-21-25 04:59AM
Aug-20-25 08:45AM
Aug-14-25 11:33PM
Aug-12-25 01:02AM
12:53AM
Aug-11-25 04:05PM
Aug-07-25 10:16AM
08:00AM
Aug-03-25 03:16PM
Jul-30-25 08:10AM
07:28AM
07:07AM
07:00AM
Jul-28-25 11:14PM
Jul-12-25 02:00PM
Jul-10-25 12:36AM
Jun-26-25 03:00PM
Jun-25-25 04:05PM
Jun-23-25 12:11AM
Jun-20-25 08:44AM
Jun-10-25 03:00PM
Jun-04-25 11:35PM
May-11-25 05:16PM
May-08-25 12:35AM
May-06-25 03:20PM
May-05-25 02:48PM
12:35AM
May-02-25 12:45PM
11:40AM
May-01-25 04:05PM
Apr-30-25 03:10AM
02:56AM
Apr-29-25 12:29PM
08:05AM
07:32AM
07:04AM
07:00AM
Apr-28-25 03:03AM
Apr-25-25 01:42PM
08:51AM
Apr-24-25 12:50PM
04:17AM
Apr-22-25 01:29PM
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients' homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RADEMACHER JOHN CHARLESChief Executive OfficerFeb 21 '26Option Exercise0.0011,0870831,506Feb 24 07:16 PM
KRAEMER HARRY M JANSEN JRDirectorNov 03 '25Buy25.9838,000987,392413,390Nov 04 04:30 PM
Wright Norman L.DirectorSep 09 '25Buy29.313,41199,97615,501Sep 10 04:18 PM
Pate R CarterDirectorAug 20 '25Buy27.1975020,39141,910Aug 21 06:26 PM
KRAEMER HARRY M JANSEN JRDirectorAug 20 '25Buy27.1536,000977,278375,390Aug 21 06:25 PM
SULLIVAN TIMOTHY PDirectorAug 21 '25Buy27.5120,000550,20049,229Aug 21 06:24 PM
GOLDING DAVID WDirectorAug 21 '25Buy27.621,00027,625116,525Aug 21 06:24 PM
Smyser CollinGC & Corporate SecretaryMay 19 '25Option Exercise0.0011,196089,715May 21 04:17 PM
Bavaro MichaelChief Human Resources OfficerFeb 28 '25Option Exercise25.4314,739374,78475,970Mar 03 05:52 PM
Bavaro MichaelChief Human Resources OfficerFeb 28 '25Sale33.2630,9961,030,84344,974Mar 03 05:52 PM
Bavaro MichaelOfficerFeb 28 '25Proposed Sale33.2330,9961,029,900Feb 28 03:41 PM